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1. Introduction: 
Inherited neuropathies can presently be divided into categories dependant on their clinical 
characteristics and include the Hereditary sensori-motor neuropathies (HSMN), Hereditary 
motor neuropathies (HMN) and Hereditary sensory and autonomic neuropathies (1 ). This 
study has focused on the familial neuropathies presenting with "peroneal muscular atrophy" 
which may be the result of disease in the peripheral nerve or anterior horn cell and therefore 
includes HSMN and HMN. 
Charcot, Marie and Tooth simultaneously described the first cases of "peroneal muscular 
atrophy" in 1886 (2, 3). The disorder which commonly presents in childhood was defined as 
slow progressive weakness and muscle wasting affecting predominantly the feet, with distal 
upper limb involvement occurring years later. With the introduction of nerve conduction 
studies Henrikson (1956) and Gilliatt and Thomas (1957), found slowed nerve conduction 
speeds in some of these patients ( 4, 5). Dyck and Lambert later recognised two common 
variants with consistent electrophysiological features in families (6). They subdivided the 
latter into HSMN type I (demyelinating/ Charcot-Marie-Tooth (CMT)-1) and HSMN type II 
(axonal/CMT-2) based on their electrophysiological evaluations. 
Less commonly encountered variants of HSMN which are all characterised by 
electrophysiological sensory and motor nerve involvement include (l); 
type III- Dejerine Sottas; 
IV - Refsum's disease ( excess phytanic acid); 
V - HSMN with spastic paraplegia; 
VI - HSMN with optic atrophy; 
VII- HSMN with retinitis pigmentosa 
(normal phytanic acid) 
Although mental retardation (7) and sensori-neural deafness (8) have been described with 
familial neuropathies, inadequate reporting or absent documentation of neurophysiological 
testing precludes these from the current classification. Involvement of the peripheral motor, 
sensory and possibly autonomic nerves may be associated with the spinocerebellar and 
olivopontocerebellar degenerations ( 1 ), but these are not included in the familial neuropathy 
classification. 
Roussy and Levy described cases in 1926 that had pes cavus, tendon areflexia, ataxia of gait 
and distal limb weakness and sensory loss with tremor in the upper limbs and claimed their 
phenotype represented a distinct entity (9) . Over the next decades many authors questioned 
the validity of their assumption, and Dyck and Lambert showed in 1968 that these individuals 
only represented a clinical variant ofHSMN I (6). 
A subgroup of familial "peroneal muscular atrophy" have been found to show 
electrophysiological involvement of only the peripheral motor system. The aforementioned 
has been classified in recent years as subcategories of hereditary spinal muscular atrophy 
(SMA) using descriptive labels dependant on the distribution of weakness. These include the 
proximal, distal, bulbospinal , scapuloperoneal, fascioscapulohumeral, oculopharyngeal and 
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bulbar "varieties of SMA" (10). SMA however refers to the particular phenotype of 
progressive proximal weakness most commonly with onset in childhood, and the gene locus 
has recently been mapped to the long arm of chromosome 5 (11). 
Classifying the pure motor component of the "peroneal muscular atrophy" group as SMA 
variants is confusing and uninformative and I have therefore considered them as hereditary 
motor neuropathies (HMN). This group like HSMN, is also clinically heterogeneous. 
Reviewing the literature in 1935, Bell concluded that the "peroneal muscular atrophies" may 
be inherited in an autosomal dominant, recessive or X-linked manner but may also occur in a 
sporadic fashion in families (12) . Recent molecular genetic advances have shown that both 
HSMN I and II are genetically heterogeneous. HSMN Ia which is the commonest, is due to 
"segmental trisomy" of band p 11.2 on chromosome 17 which is also the locus for peripheral 
myelin protein-22 (PMP-22), the candidate gene for type Ia (13,14,15,16) . HSMN lb has 
been linked to the Duffy blood group marker located on chromosome 1 q (17), and the 
X-linked families to the long arm of the X chromosome (18,19) . 
HSMN Ila has recently been linked to markers on chromosome lp36 (Vance Jet al. In Press). 
Type II has been classified further into Ilb and Ile where the gene is unknown in both 
instances, but the latter is associated with vocal cord paralysis ( personal communication, 
Harding AE; 1993). 
Apart from the familial motor neurone disease subcategory, no chromosomal linkage has been 
established in HMN. The former has been linked to chromosome 21 in certain families and 
mutations in the Cu/Zn-binding superoxide dismutase gene on chromosome 21 has recently 
been demonstrated in these families (20). 
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2 Objectives: 
1. The primary aim of this prospective study was to determine the phenotypic 
spectrum of the inherited neuropathies seen in individuals at Groote Schuur Hospital between 
May 1990 and January 1993 . The patients were classified according to their clinical and 
neurophysiological phenotypes, as well as inheritance patterns within their respective families. 
The phenotypic groups have been examined for common or characteristic clinical features 
such as symptoms and their time of onset, dysmorphic features and the degree of functional 
disability. Racial and gender differences have also be delineated. These features have not 
been documented before in our population, and are not only essential for neurologists 
providing clinical counselling for such families, but will provide an accurate clinical database 
for further genetic studies. 
2. Secondly, with respect to the HSMN group, I intended to asses linkage to the 
Duffy blood group locus on chromosome 1 by determining LOD scores in large families 
where individuals from at least 2 generations were examined and found to be affected. It was 
my intention to then compare the phenotypic expression of these families to non-linked 
families . The families that do not display linkage to chromosome 1 will be examined at a later 
date by the Department of Genetics with the use of DNA probes, for linkage to chromosome 
17 and X. 
3. Method: 
3 .1. The patients' names were selected from the records of the neurophysiology 
laboratory of the Neurology unit and the Department of Human genetics. 
3.2. Patients were notified of the proposed study and invited to participate after 
informed consent had been obtained. 
3.3. Index cases were included in the study when; 
a) there was a chronic history of weakness in the 
distal legs and arms; 
b) with or without a positive family history; 
c) electrophysiological evidence of motor or 
sensori-motor involvement. 
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3.4. The index cases, with as many symptomatic and asymptomatic family members as 
possible, were examined neurologically and electrophysiologically. All clinically affected 
members were questioned to exclude other possible causes for their neuropathies and the 
index cases underwent a routine laboratory screen to exclude known causes of neuropathy. 
3.5. The functional impairment in affected individuals were evaluated by determining a 
total neurologic disability score (NDS-T) for each case. This is a predetermined set of 
evaluations scoring motor weakness (NDS-W), deep tendon reflexes (NDS-R) and certain 
sensory (NDS-S) parameters as follows (21): 
Muscle weakness - 0 = normal strength 
- 1 = 25 % decrease 
- 2 = 50 % decrease 
- 3 = 75 % decrease 
- 4 = 100 % decrease 
Reflexes - 0 = normal 
- 1 = unequivocally decreased 
- 2 = absent 
Sensation for the index finger and great toe were graded as for the reflexes. 
A score for muscle weakness (NDS-W) was determined in the following muscle groups; in the 
arm for shoulder abduction, elbow flexion and extension, wrist flexion and extension, and 
finger abduction and flexion. In the legs a muscle weakness score was determined for hip 
flexion and extension, knee flexion and extension, ankle dorsiflexion and plantar flexion and 
toe flexion and extension. If toe extension and ankle dorsiflexion was evaluated to be 50% 
weak in both legs, the score would be NDS-W: 2x2 + 2x2 =8. The grading depended on the 
examiners concept of what was normal considering the age, sex and physical fitness of the 
individual. When a unilateral focal nerve injury or surgical procedure interfered with the 
grading of the deficit due to HSMN, the values from the uninjured side were used for the 
injured side. 
Sensation was evaluated with respect to pain, touch and position sense. If both great toes 
showed an unequivocal reduction in touch sensation (2 x 1) with normal proprioception (0) 
and absent pain sensation (2 x 2), the total NDS-S score would be 6, assuming the sensation in 
the fingers were normal. 
A NDS-T score was determined for each subject by adding the respective scores for NDS-W, 
NDS-R and NDS-S for that particular individual. 
Gait was assessed and scored objectively as; 
0- normal; 
1- footdrop; 
2- complete footdrop requiring ankle-foot orthoses; 
3- requiring crutches; 
4- requiring wheelchair intermittently; 
5- wheelchair bound. 
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All the neurological examinations were performed by the author and were done prior to nerve 
conduction studies. 
3.6. Nerve conduction studies were performed on symptomatic and 
asymptomatic individuals under standard conditions according to our laboratory protocol on a 
Medelec Mystro GR 20. Limb temperatures were measured and kept constant with a bath 
and/or warming lamp. Arm temperatures were maintained above 31 .5 °C and leg 
temperatures above 30.5 °C as measured at the wrist and ankle. Electrophysiological nerve 
conduction responses were measured with suprathreshold stimuli . 
Motor nerves were examined electrophysiologically with the active surface electrodes (Gl) 
over the mid-position of the muscle belly and the reference electrode (G2) over the tendon of 
the same muscle. The nerve was stimulated 8 cm proximal to the G 1 electrode. In children 
less than 5 years the distance was 5 cm but these distal latency values were not included in 
calculations. Motor amplitudes were measured from the baseline to the negative peak. 
Median and ulnar digital sensory conductions were performed via orthodromic stimulation and 
the sural sensory nerve via antidromic stimulation. The distance between the stimulating 
electrode and the G 1 surface pick up electrode was 14 cm in all cases. The distance between 
the active and reference electrode was 2.5 cm and both were placed directly over the nerve. 
The sensory amplitudes were measured from peak to peak after eight responses were 
averaged, and the sensory latency was measured form onset to peak. 
Nerves examined electrophysiologically included (where possible); 
• Right Common Peroneal nerve (CPer) (motor) 
• Right Post Tibial nerve (PTib) (motor) 
• Right Sura! nerve (sensory) 
• Right Ulnar motor and digital (sensory) nerves 
• Right Median motor (Med) and digital (sensory) nerves 
The electrophysiologic study in all index cases included electromyography (EMG) with a 
standard concentric needle electrode. All family members, affected or unaffected, were 
clinically and electrophysiologically examined but needle examinations were only performed in 
these individuals when consent was given. 
3.7. Blood was drawn for Duffy blood group typing by the 
Provincial laboratory for Tissue Immunology. LOD scores were determined to assess linkage 
to chromosome I using the LIPED programme (22) . DNA was also freeze-stored by the 
Department of Genetics (UCT) for DNA probe evaluation at a later date (separate study). 
10 
Results: 
This prospective series comprises all the patients with electrophysiological evidence of motor 
with or without sensory dysfunction, examined at Groote Schuur Hospital between May 1990 
and January 1993 that satisfied the clinical inclusion criteria. A total of 7 5 affected patients 
from 3 8 pedigrees were examined. The patients have been classified into 3 groups according 
to electrophysiological and clinical features (Table 4.1 ); 
!)hereditary sensory-motor neuropathy (HSMN) group (n=58: 25 families) ; 
2)hereditary motor neuropathy (HMN) group (n=l2: 11 families) ; 
3)hereditary sensory and autonomic neuropathy (HSAN) group (n=S : 2families). 
The results will be presented separately for each group. Statistical analyses were done using 
the SSPS computer programme under the supervision of Mr S Isaacs from the Department 
Biostatistics at Groote Schuur Hospital. Statistical analysis of the data was performed using 
the Student-T test. 
TABLE 4.1: Demographic data. 
Sensori-motor(HSMN) 
Type I: Inheritance 
Dominant 
Recessive/Sporadic 
X-linked? male 
X-linked? female 
Type II Inheritance 
Dominant 
Recessive/Sporadic 
Motor(HMN) 
Sensory-autonomic 
(HSAN) 
mAge - mean Age at assessment 
SA racial groups: 
Ml A : mixed-ancestry 
W : white 
B : black 
I : indian 
cases mAge(years) race 
31.1 
38 29.8 
2 22.5 
3 21.0 
5 47.6 
41.8 
1 72 
9 38.4 
12 35.3 
5 40 
19MIA 
19W 
1 MIA 
1 B 
3 W 
5W 
IW 
4 B 
4 MIA 
lW 
6W 
3 MIA 
2 I 
1 B 
5 W 
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4. HEREDITARY SENSORY-MOTOR NEUROPATHY GROUP (HSMN): 
There were 58 affected cases in this group with a mean age of 32 years, comprising 23 index 
cases, each from a different pedigree, and 35 affected relatives. All the patients in this group 
had clinical and electrophysiological evidence of sensory and motor dysfunction. The 
predominant racial subgroup was of mixed ancestry ethnic origin (Table 4.1 ). 
A value for motor conduction velocity for the median nerve was obtained in 50 cases and for 
the peroneal nerve in 29. In 26 cases a value could not be obtained for the peroneal nerve as 
the extensor digitorum brevis muscle was totally denervated. In only 1 case could a proximal 
median nerve response at the elbow not be obtained, due to markedly reduced distal motor 
unit potentials in the abductor pollicis brevis muscle. Figure 1 shows the distribution of motor 
conduction velocities for the median nerves. 
4.1 Classification: 
The HSMN group could be divided into 2 groups based on electrophysiological criteria, as 
previously described (fig. I) : 
-HSMN I or demyelinating variety of Charcot Marie Tooth 
(N=48); 
-HSMN II or axonal variety of Charcot Marie Tooth 
(N=lO). 
These two groups were divided according to their mean distal latencies (DL). (Table 4.2) 
This method was used in an attempt to increase the objectivity of the division in conduction 
speeds, by using an additional parameter of distal nerve conduction velocity. 
The HSMN I cases all had median (Med) nerve DL's slower than 130% of the upper limit of 
normal with a mean Med DL of 229 % of the upper limit of normal (Range 6.3- 17.1 msec; 
Normal < 4.5 msec) The mean median conduction velocity (Med CV) was 22.2 meters per 
second (mis) (SD 7.9; n=35) with a range of 12.8 - 33.1 mis (Normal > 48 mis) . Median 
nerve DL values were not included in children where it was not possible to use the adult 
distances. There were individuals that refused an upper limb examination after the leg 
examination. 
Group II (N =10) all had normal distal latencies with a mean Med DL of 88 % of the upper 
limit of normal (Range 3.3- 4.9 msec.). The mean Med CV was 43 .7 mis (SD 7.81 ; range 34.8 
- 54.4 mis). A statistically significant difference (p=0.000) was found between the mean Med 
CV ofHSMN I and HSMN II. A mean Med CV of less than 33 .1 mis therefore corresponded 
to the HSMN I group and a value over 34.8 mis to the HSMN II group. 
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The unaffected relatives of both groups I and II had a mean Med DL of 3.66 msec (SD= 0.37) 
and a mean Med CV of 55 .63 mis (SD= 5.48). The former did not differ significantly from the 
HSMN II (p= 0.037) but the mean Med CV of the unaffected relatives did differ from HSMN 
II (p= 0.000). 
Table 4.2: HSMN Classification 
mMedL(ms) (SD) mMed CV(m/s) (SD) 
HSMNI 10.17 (3 .19) 22.17 
HSMNII 4.00 (0.52) 43 .72 
P= 0.000 0.000 
mMed DL - mean Median nerve distal latency 
mMed CV - mean Median nerve conduction velocity 
4.2 Inheritance patterns: 
(7.90) 
(7.80) 
Autosomal dominant (AD) inheritance was observed in the majority of type I individuals (12 
families) with the exception of only 2 families with possible Autosomal recessive or sporadic 
(ARIS) inheritance. Nine HSMN II cases showed predominant ARIS as a possible inheritance 
pattern with 1 family having AD inheritance according to the family history (see Table 4.1). 
The HSMN I ARIS cases had a mean Med CV of 15.3 mis (SD= 0.4) which did not differ 
significantly from the HSMN I AD cases with a mean Med CV of22.2 mis (SD= 5.7: p= 0.10) 
These results are in contrast with those of other investigators (7, 15) in which a significantly 
slower median conduction velocity was found in the autosomal recessive cases. Although the 
Type I ARIS sample size consists of only 2 cases, statistical analysis was performed due to the 
negligible variance. 
Two families had a distinctive phenotype suggesting X-linked ('XL') inheritance which 
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distinguished them from the rest of the HSMN I group; 
I) In family Q (see Fig VII) case Ill was moderately affected (NDS-T=40). (see section 3). 
The rest of the family, apart from the mother(Il ), was unaffected. She was asymptomatic but 
had minimal objective clinical involvement (NDS-T=8) and absent sensory responses in the 
upper and lower limbs on electrophysiological examination. The motor conductions were 
normal and EMG was refused. This unusual pattern could be consistent with X-linked 
recessive inheritance pattern (personal communication AE Harding) . 
II) Family B (see Fig VIII) was characterised by no male to male transmission of the trait in 4 
generations, as well as a significant number of asymptomatic female cases that were 
subsequently found on testing to be affected . Furthermore, a significant difference in motor 
conduction velocities between affected males ('XL-M') and "carrier" females ('XL-F') was 
also found . (Table 4.9) These clinical results have to be confirmed with DNA studies. 
4.3 Symptoms: 
Symptom onset in HSMN I, AD and ARIS, occurred predominantly in the first decade. (Fig. 
II) HSMN 'X-L M ' (n=3) experienced, symptoms initially in the first (n=l) and second 
decade (n=l), but one individual was still asymptomatic at age 23 years. Other asymptomatic 
individuals, who were subsequently found on clinical and electrophysiological examinations to 
be affected, included four subjects from type I AD families with mean Med CV 18.9 mis and a 
mean NDS-T score of 15 .5, and three 'XL-F' in the probable X-linked family (cases B IV8; B 
V2; B III6; See Fig VIII) who had a mean Med CV of 46.5 mis and a mean NDS-T score of 
6.5 points. 
HSMN type II presented with symptoms predominantly in the second decade (n=8), with one 
HSMN type II AD index case experiencing his first symptoms in the 5th decade. (Fig. II) 
There was no difference in the presentation of symptoms or their frequency between HSMN I 
and II (see later). 
There were 4 type I families in which a number of individuals from 3 generations were 
examined. It appeared as if each subsequent generation experienced earlier onset of symptoms 
than the preceding one. (Table 4.3) Generation numericals were assigned in most instances, 
according to when the symptoms of the disease first appeared in the family . 
Table 4.3 Age of onset in successive type I generations (yrs): 
Generation: 
Family A* 
Family O• 
Family R• 
Family H# 
* Fig IX 
• Fig X 
# Fig XI 
I 
63 
50 
35 
23 
15 
II 
8 
25 
4 
27 
15 
15 
5 
15 
15 
m IV 
2 
3 
5 
10 15 
5 
8 4 
15 
V 
5 
5 
The earliest and commonest symptoms experienced in HSMN were ankle instability and 
clumsiness (68%). The other common symptoms were difficulty with walking (49%), cramps 
(39%), weakness of the legs and cold feet (28%), persistent toe walking during childhood 
(16%), and patella dislocation (7%). (Table 4.4) Cramps were only considered significant if 
they occurred more than once per month for at least six months, and they were usually 
experienced in the fingers or toes after exercise. A number of patients also experienced 
frequent nocturnal calf cramping. The only symptoms in unaffected family members ( n=3 7) 
were cramps in 2 individuals and an episode of patella dislocation in 1. Weakness of the hands 
were experienced by 28% of the subjects with the onset occurring predominantly in the 4th 
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were experienced by 28% of the subjects with the onset occurring predominantly in the 4th 
decade. Sixteen percent of the affected individuals complained of numbness in the feet and 
occasionally in the hands. None of the patients had experienced paresthesiae. 
Recumbent positional dyspnoea was a complaint in one HSMN I individual (age=62 yrs). 
Examination revealed paradoxical diapraghmatic respiratory movement and his Forced Vital 
Capacity in a standing and lying position were 1100ml and 600ml respectively. Phrenic nerve 
conduction studies showed a consistent CMAP response with a delayed latency on the left 
(DL= 24.9 msec; normal= 6.9-9.2 msec), and no response could be obtained on the right. 
This patient had a Med-CV of 19.2 mis in 1983, but I was only able to obtain a delayed distal 
motor response (Med DL = 9.9 msec.) without a proximal response during the most recent 
examination (1991) . The disability score (NDS-T) at the time of examination was 98 and he 
was able to walk with ankle-foot orthoses and a walking stick. 
TABLE 4. 4: SYMPTOMS IN HSMN. 
SYMPTOMS n=57* 
Ankle instability 39 
Clumsiness 39 
Gait difficulty 28 
Cramps 22 
Cold feet 16 
Weakness/feet 16 
Hand weakness 16 
Numbness 9 
Toe walking 9 
No symptoms 8 
Patella dislocation 4 
Dyspnoea(positional) 1 
* 1 case from Type II family had severe complicated Tuberculous meningitis. 
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4.4 Dysmorphic features 
Pes cavus, wasting of distal legs and clawing/hammering of the toes were the commonest 
dysmorphic features in type I and II HSMN. Wasting of the muscles of the hands and 
forearms were more frequent in type II (80%) than type I (46.8%), whereas hand clawing due 
to presumed disproportionate distal weakness and finger flexor contractures, was found in 2 
HSMN I subjects and I HSMN II. 
Three HSMN I and I HSMN II individuals had no evidence of the abovementioned 
dysmorphic features, whereas 84,6% unaffected family members had no such features . 
Dysmorphic features in the latter group included hyperextensibilty of the joints (n=l), narrow 
forehead, stubby fingers and small hands & feet in one child with profound mental retardation 
(n=l) and pes cavus (n=4) . The latter included adult and child (older than 5 years) relatives 
who exhibited arching of the lateral and medial aspect of the feet , off a flat surface. These 
individuals however had normal neurological and electrophysiological examinations. 
Table 4.5 DYSMORPHTC FEATURES in HSMN: 
Distal leg wasting 
Pes cavus 
Toe clawing & hammering 
Wasting of the hands/forearms 
Webbed fingers 
Hand clawing 
Hyperextensibilty of joints 
Scoliosis 
Toe syndactely(2nd & 3rd) 
Webbed neck 
Blepharophimosis 
Genu valgus 
n=58 
35 
44 
23 
22 
5 
3 
3 
2 
I 
I 
I 
I 
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4.5 Signs: 
Postural tremor did not entirely co-segregate with HSMN I in any of the kinships. (Table 4.6) 
Tremor in the upper limbs were found in 64.9% of HSMN I, 2 unaffected relatives and in 2 
HSMN II patients. Tremor was not observed in the presumed X-linked families . 
Table: 4. 6 Tremor in HSMN I families: 
Family CASES TREMOR NO TREMOR 
• A 10 3 7 
• C 1 1 
• E 1 1 
• F 4 1 3 
• H 4 4 
• J 1 1 
• K 1 
• L 1 1 
• 0 
,., 
1 2 .) 
• p 1 1 
• R 6 3 3 
• s 5 5 
Mental retardation was evident in 1 HSMN I (n=37) case, 2 affected sisters with HSMN II 
(n= lO) and 3 of the unaffected family members (perinatal trauma in 1 case; n=39) . 
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Clinical evidence of nerve thickening at the fibula head and ulnar groove was found in only 
54.1 % of HSMN I cases who were classified as such on subsequent electrophysiological 
testing. I found the presence of nerve thickening therefore a reliable clinical sign of a 
demyelinating neuropathy. One HSMN type II subject also had evidence of clinically 
thickened nerves. 
Complete areflexia was present in 38% (n=14) of HSMN I and 60% (n=6) of HSMN II 
individuals. Normal deep tendon reflexes were found in 6/37 of HSMN I cases and 2/5 of 
'XL-F'. All the HSMN II cases had abnormal reflexes. Hyperreflexia and extensor plantar 
responses were not found in any of the patients. 
Motor examination revealed lower limb distal weakness in HSMN I and II predominately in 
the anterior tibial and peroneal muscle groups. Ankle dorsiflexors were at least 50% weaker 
than the plantar flexors in 40% of the HSMN cases that had not undergone any surgical 
procedures to their feet. The reverse was found in only 2 cases where plantar flexors were 
50% weaker than ankle dorsiflexors. The leg weakness usually did not progress more 
proximally than the distal thighs. Weakness in the arms usually involved the fingers with 
resultant hand clawing, and mild wrist weakness. Upper limb involvement proximal to the 
elbows was not found in any of the affected subjects. 
Sensory involvement was usually mild, although the HSMN II subgroup showed the greatest 
clinical sensory dysfunction (Table 4.8). As with motor involvement, few patients experienced 
subjective sensory impairment. None of the patients complained of paresthesiae or lancinating 
pains which is not part of this syndrome (1). Severe sensory loss with perforating ulcers were 
not encountered in any of the HSMN cases. 
Scoliosis was found in 2 HSMN I patients; the 1 case (16 yrs) came from an autosomal 
recessive/sporadic pedigree and had experienced symptoms for 1 decade; the other case (26 
yrs) also suffered from mental retardation, had experienced symptoms for at least 2 decades 
and came from a definite autosomal dominant family. 
Objective gait assessment in HSMN I showed that 40.5% of cases walked normally; 43 .2% 
had mild foot drop; 13 .5% needed ankle -foot orthoses and a further 5.4% required additional 
crutches for ambulating. The 'XL-M' cases all had mild footdrop, whereas the 'XL-F' (n=5) 
walked normally. None of the 10 HSMN II subjects walked normally; 3 had mild footdrop; 3 
needed ankle-foot orthoses; 1 required crutches to walk; 1 used a wheelchair intermittently 
and 1 patient was wheelchair bound (4th decade). 
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4.6 Neurologic disability score (NDS) 
Functional disability as determined by the neurologic disability score was most severe in the 
type II families (NDS-T= 72.1; SD=23.0) compared to type I (NDS-T= 35.3; SD=22.8). 
Unaffected family members (n=39) had disability scores of zero apart from 4 individuals who 
each had a total disability score of 2 due to reduced ankle jerks (mAge= 43 years) . 
In the HSMN I group with autosomal dominant inheritance, there was no objective difference 
in neurological disability between the sexes in each of the different categories. (Table 4.7) 
Disability scores in the 'X-linked' families also showed no significant difference between 
'XL-M' (NDS-T= 35; SD 4.4) and 'XL-F' ( NDS-T= 21.6; SD 15.4) despite the fact that 
most of the latter had no symptoms (p=0.3). The small sample size, greater mean age and 
much variance about the mean of the 'XL-F group could produce an erroneous conclusion. 
(Table 4.6) 
The mean disability score for HSMN I ARIS (mean NDS-T= 56) was greater than that for 
HSMN I with autosomal dominant inheritance (NDS-T= 33 .4). Statistical comparisons were 
not performed due to the small sample size (n=2) in the former. 
Total neurologic disability showed a linear relationship with increasing age (fig. III; p=0.004, 
r=0.40) in HSMN I and II. However a bar graph (Fig. IV) depicting the duration since 
subjective onset and objective disability (NDS-T) does not show an unequivocal increase in 
disability with increasing disease duration. It is noteworthy however that in some of the 
columns there was only one patient which precluded the calculation of a mean value. 
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Table 4.8 :Comparison of age, median conduction velocity and functional disability (NDS) 
in HSMN I and IT and HMN. 
Cases(n) 
mAge yrs 
HSMNI 
37 
29.8 
mMed CV 21 .7 
mis 
mNDS-W 
mNDS-S 
mNDS-R 
mNDS-T 
m = mean 
22.3 
6.9 
11.9 
35.3 
mAge- at assessment 
10 
41.8 
43 .7 
45 .0 
12 
15.1 
21.6 
22 
4. 7 Electrophysiological characteristics 
The patients were classified into the HSMN I or HSMN II groups according to the distal 
conduction velocities of the median nerves (see section 4.2). No electrophysiological 
abnormalities were found in any individuals with normal clinical examinations. 
The Med CV range for HSMN I was 12.8- 33 .1 mis and for type II, 34.8- 54.4 mis. The clear 
separation of these 2 groups supports our method of classification. 
There was no significant gender difference in the mean Med CV's between males (17.0 mis) 
and females (20.5 mis) in HSMN type I or II. (Table 4.9) Families with possible X-linked 
inheritance were not included in these calculations. The latter group however showed a 
significant gender difference between 'XL-M' with a mean Med CV= 31.4 mis (SD= 1.1), and 
asymptomatic affected females('XL-F') who had a mean Med CV= 46.9 mis (SD= 8. l)(p= 
0.019). (Table 4.9) . 
TABLE 4.9 MEDIAN NERVE CONDUCTION VELOCITY vs GENDER: 
SEX 
MALE 
FEMALE 
* p=0.31 
n 
14 
17 
mMED CV- mean Med CV 
HSMN(excl. X-L) 
mMEDCV 
16.97 
20.53 
SD 
10.51 * 
8.58* 
HSMN I individuals from families with an autosomal dominant inheritance pattern, had a 
significantly slower median nerve conduction speed to males in the proposed X-linked families 
whom exhibited only moderate slowing of nerve speed (p=0.005) 
In an attempt to evaluate the uniformity of the disease process I compared the conduction 
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velocities of 2 upper limb motor nerves. No significant difference was detected in the Median 
and Ulnar nerve conduction velocities in HSMN I (p > 0.1) Table 4.10. Statistical analyses 
were not performed for the other subgroups in Table 4.10 due to their small sample size. 
HSMN II however, appears to follow the same trend as HSMN I. The proposed 'XL-M' and 
'XL-F' how an apparent difference between the aforementioned nerve speeds, and this may be 
a useful electrophysiological clue for the identification of this subgroup from HSMN I. 
Table 4.10 COMPARISON of MEDIAN and ULNAR NERVE CONDUCTION in HSMN 
g-roups (mis) 
MED 
ULN 
Normal:- MED (Median) CV= 48-66 mis 
ULN (Ulnar) CV= 51-71 mis 
m# = mean (mean normal CV - patient CV) 
* p> 0.1 
HSMN II 'XL-M' 
(n=lO) (n=2) 
mCV mCV 
43 .7 31.4 
46.83 42.1 
'XL-F' 
(n=4) 
mCV 
46.9 
55.1 
There was no significant difference in nerve conduction velocities between the HSMN I 
propositi and affected members of the same kindred, excluding the 'X-L' cases. (Table 4.11) 
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Indirectly this serves as further evidence against a relationship between nerve conduction 
speed and disability if the propositus, whom is the individual presenting with the symptoms in 
the family, is considered the most functionally disabled. In the proposed X-linked family the 
mean Med CV of the 'XL-M' (propositi) differed from the 'XL-F' cases. 
Table 4. J J Median conduction velocity (mis) in Propositi and Affected relatives 
HSMNI 
Propositi 
Relatives 
X-LINKED 
Propositi (male) 
Relatives 
(female) 
* p= 0.06 
n 
6 
19 
2 
3 
mean 
28 .20 
22.53 
30.75 
46.86 
SD 
6,72* 
9.16* 
0.07 
8.12 
No significant correlation between median motor conduction velocity and the age of the 
affected individual could be shown. (fig. V) (r=O 07; p= 0.14) 
The sensory nerve action potentials (SNAP's) were entirely absent in the sensory nerves tested 
(see section 3) in 24/27 HSMN I cases and 2/9 HSMN II cases. Reduced SNAP's in the upper 
limbs associated with absent sural nerve SNAP's were found in only 2/27 type I and 4/9 type II 
cases. In the upper limbs both median and ulnar SNAP's were unrecordable in 25/26 type I 
and 3/9 type II individuals. An absent SNAP in one of the two aforementioned upper limbs 
motor nerves, together with a reduced response in the other, was found in 1/27 Type I and 3/9 
Type II cases. 
In most patients the electromyographic examination consisted of sampling four quadrants in 
three muscles although some cases could only tolerate needling of 1 or 2 muscles. Needle 
examination in both HSMN I and II showed fibrillation potentials and positive sharp waves in 
more than 60% of cases examined, but fasciculations and chronic repetitive discharges(CRD's) 
were not frequently seen. The motor units are characteristically large, polyphasic and with 
voluntary activation showed a pattern of reduced recruitment. 
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Longitudinal studies of nerve conduction speed was only available in a few individuals that had 
been studied by our department in previous years. Progression of nerve conduction slowing 
was not observed in any of these patients (Table 4.12) which included an affected male and 
female from our proposed 'X-L' HSMN I family . In 2 individuals the distal leg CMAP's 
became unrecordable within a 2-4 year period due to progressive denervation of the distal foot 
muscles. 
Table 4.12 Longitudinal data of nerve conduction velocity (mis) 
Patient 
U 111 
BIV6* 
* X-LF 
l; X-LM 
1976 
1979 
1988 
1991 
1976 
1991 
1983 
1991 
1979 
1992 
1988 
1992 
1986 
1988 
# conduction block at elbow 
nd- not done 
NR- no response 
CPERCV 
19 
22 
17.4 
nd 
nd 
NR 
29.7 
NR 
33 .3 
NR 
MED CV 
nd 
nd 
26.4 
27.3 
nd 
34.5 
37.2 
36.0 
35. I 
45 .3 
43.4 
35 
30.8 
Ulnar CV 
18 
19 
nd 
18.6 
24 
38.5 
44.5 
50.0 
38.0 
21 .6# 
26 
27 
4.8 Genetic Linkage Studies 
Duffy linkage analyses were performed in 6 families where more than three affected members 
from at least two generations, were examined. Family T (Table 4.13) however, had only 2 
affected sisters and the family was thus analysed as having an autosomal recessive inheritance 
pattern. Linkage to chromosome 1 was excluded in family O (LOD scores = -2). The 
remainder of the families apart from Family L, all showed negative LOD scores. In family L 
the LOD score showed a tendency toward 0.1 with decreasing recombination fractions.(Table 
4.1) Unfortunately the remainder of the family refused to be examined and we could therefore 
not increase the sample size and thereby get a more definitive result with respect to linkage to 
chromosome 1 in this family. 
Table 4.13 LOD scores for Duffy Linkage Analysis program LIP ED (5) 
RECOMBINATION FRACTI0N(8) 
Family 
0.4 0.3 0.2 0.1 0.05 0 
A -0.01 -0.0 -.14 -0.19 -0.26 -0.34 
T* -00 -00 
-0.01 -0.01 -0.01 -0.01 
R -00 -.02 -0.05 -0.09 -0.13 -0.18 
H -0.02 -0.07 -0.19 -0.44 -0.7 -1.9 
0 0.03 -0.01 -0.16 -0.49 -0.84 -2.62 
s -00 -00 -00 
-0.01 -0.01 -0.01 
L 0.02 0.03 0.05 0.06 0.07 0.08 
* ARIS family - program applied to AR linkage program. The other families analysed as AD 
inheritance patterns. 
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4.9 Discussion: 
The HSMN type I and II (Charcot-Marie-Tooth Syndrome) are known to be the commonest 
encountered familial neuropathies with an occurrence of approximately 36 per 100,000 in 
studied populations (19) . Although the local prevalence is not known, it was interesting to 
note that a "neuromuscular research program" at a Dutch university hospital only diagnosed 
109 patients with HSMN (68 cases with HSMN I) over a 20 year period, compared to our 57 
cases in 3 years (23). It is therefore reasonable to presume that the previously defined 
subgroups of HSMN type I and II are also commonly encountered in the South African white 
and mixed ancestry ethnic groups. The data interpretation for black patients in this series is 
extremely difficult as various socio-political factors could be contributing very significantly to 
the low number of diagnosed cases. HSMN III was not encountered in this series. 
Although there is clinical phenotypic heterogeneity in both HSMN I and II, the 
electrophysiologic evaluation is abnormal in the distal limbs of all affected individuals. All the 
patients that were found to be affected clinically were found to be electrophysiologically 
affected even though some of them were asymptomatic. Motor nerve conduction slowing in 
type I individuals may however not be fully developed until 3-5 years of age (24). Patients 
of this age generally tolerate the examination of at least 1 nerve. I, as well as others have 
shown that the conduction slowing was uniform in all the electrophysiologically examined 
nerves and a reasonably confident diagnosis of autosomally inherited type I disease could 
therefore be made at this age, provided that age appropriate normal conduction speeds are 
used for comparison. (Table 4.10). 
The Median nerve conduction velocity was used for the electrophysiological classification of 
patients, as the peroneal nerve conduction was often unrecordable due to denervation of the 
Extensor Digitorum Brevis muscles. The conduction speed segregation point for division of 
HSMN into Type I and II in this study, differed from previous studies. Evaluating conduction 
speeds in their populations, Harding et al. (25) and Dyck et al. (9) found segregation occurring 
at 38 mis and 40 mis respectively. This series however shows a segregation point at 
approximately 33-34 mis with complete concordance of median conduction speeds in families, 
excluding the probable X-linked families. (Table 4.2) 
I have shown that Med DL measurements in conjunction with Med CV scores improves 
classification accuracy, particularly when Med CV in a warmed limb falls between 34 to 38 
mis. 
Harding (26) found autosomal dominant inheritance to be the commonest mode of inheritance 
in type I and II, but locally the ARIS pattern was found to predominate in type II families. As 
I was unable to examine most of the family members in the latter group, I have assumed 
inheritance patterns on the basis of the history in the majority of the type II cases with the 
exception of a Xhosa family. In this family 2 out of 4 siblings were affected with unaffected 
non-consanguineous parents (1 examined; 1 by history; Fig. XI-family T) . (Table 4.1) 
The HSMN I phenotype has been shown to be associated with at least three chromosomal 
locations of which the X chromosome and chromosome 1 linkage are the least frequently 
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encountered. The commonest genotype in type Ia is a gene duplication at band pl 1.2 on 
chromosome 17 which is thought results in overexpression of the candidate gene, peripheral 
myelin protein-22 (PMP-22) (13, 14, 15, 16, 27). PMP-22 is a myelin molecule produced by 
the Schwann cells in the peripheral nervous system (28) . 
Sporadic cases may occur if the repeat sequences at 17p 11.2 misalign during meiosis resulting 
in unequal cross-over and submicroscopic gene duplication (29, 30). If the l 7pl 1.2 locus 
undergoes an interstitial deletion however, the phenotype of hereditary neuropathy with 
liability to pressure palsy (HNPP) results (31 ). This suggests that underexpression of the 
PMP-22 gene results in the predisposition of peripheral nerves to demyelination in response to 
minor trauma as occurs in HNPP (31 ). Nerve histology shows unravelling of myelin lamellae 
in HNPP and the PMP-22 gene may code for a cell adhesion molecule important in 
maintaining myelin adherence (31 ). Partial deletion of band p 11 .2 on chromosome 17 has also 
been found in patients with an axonal neuropathy, developmental delay, abnormal sleep 
function and specific behavioural abnormalities (32) . 
HSMN lb, an uncommon genotype in previously reported populations, are those families 
where linkage has been demonstrated to the Duffy blood group marker located on 
chromosome lq (17) . The LOD score is the logarithm of the odds ratio for linkage of a 
marker locus with a disease locus, and the conventional LOD score for accepting the linkage 
hypothesis is a value of 3 at a given recombination distance (8) (22) . We have not 
demonstrated linkage to the Duffy antigen in any of these South African families although 
linkage could not be excluded in 1 family (Table 4.12; family N). 
A third subgroup of the HSMN I phenotype (X-L) has been shown to be linked to the long 
arm ofthe X-chromosome (Xql 1-q13) (18, 19). Although this genotype is uncommon with an 
estimated frequency of 3.6 per 100,000 and our clinical data have not yet been substantiated 
with DNA analyses, we base our assumptions of a probable X-linked dominant pedigree (fig. 
VIII) in our series on the following features; 
a) no male-to-male transmission in 4 generations; 
b) 90% of the females that were found to be affected clinically and electrophysiologically, 
were asymptomatic; 
c) males had slower mean Med CV than the "affected" females and would therefore be 
classified as type I, yet the females could be classified as type II . This gender difference is 
apparent in reported X-linked families (33) and was not found in HSMN I or II . It is well 
documented that despite clinical and symptomatic heterogeneity in HSMN type Ia and lb, the 
kinships always display an uniform electrophysiological picture (6, Table 4.11); 
d) there was however no significant gender difference in the calculated functional disability 
between 'XL-M' and 'XL-F individuals. Despite the aforementioned comparable disability 
scores, the majority of the ' XL-F' subjects were asymptomatic. Although this could suggest 
a more insidious pathological process in the females with greater functional adaptation and 
less symptoms, I feel the small sample size and the significantly older age of the females 
precludes further interpretation. 
No distinguishing clinical or electrophysiological features could be determined between males 
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of HSMN I AD and HSMN I 'X-L' which supports the pathological similarities. Both are 
characterised pathologically by segmental demyelination and onion bulb formation (33, 34) 
Prediction of this phenotype can therefore presumably only be made by clinical or 
electrophysiological examination of the female subjects in the pedigree . 
A X-linked recessive form of type I inheritance has also been described and we possibly have 
such a family in our series as well (19) . (see fig . VII) 
Autosomal recessive inheritance has been described in HSMN I where scoliosis and teenage 
wheelchair dependency is said to be common (23 , 35). Other features mentioned by the 
authors such as abnormal motor development from the first year of life with persistent toe 
walking, clumsiness and poor running, I also found in certain HSMN I AD family members. 
Such cases were often the product of third or subsequent affected generations. It is unclear 
without genetic studies, whether this is the result of anticipation in these families, or just 
increasing awareness of "tell-tale" signs amongst family members in subsequent generations. 
The conduction velocities of these reported HSMN I AR cases are also comparable to this 
series' HSMN I AD cases, and I suspect that at least some of these presumed AR cases are 
type I "new" mutations. 
It is well recognised that HSMN II also occurs in an autosomal dominant and recessive form 
as is seen in this series, but the exact chromosomal location is unknown. Some authors have 
reported a subgroup of HSMN II with recessive inheritance that presented in childhood 
(usually 18 months to 4 years) and is more disabling (36) . Nine of the 22 cases were 
wheelchair bound in their 2nd or 3rd decade. Some of these children were also found to have 
optic atrophy, deafness and mental retardation. Even though sporadic or autosomal recessive 
inheritance is highly represented in this local type II group, I have not encountered cases with 
the aforementioned phenotype. 
The appearance of first symptoms in the 2 subgroups of HSMN was similar to previous series' 
with HSMN II patients presenting in the second decade and type I in the first. One individual 
with HSMN type II, however developed his first symptom as late as the seventh decade. 
Eight percent of the affected HSMN individuals were asymptomatic (age range 9- 31 years) 
and if the 'X-L' families are included, the figure increases to 17%. Harding (26) also found a 
substantial number of asymptomatic (> 10%) affected individuals. This also highlights the 
importance of accurate clinical and electrophysiological examination in families for genetic 
counselling and research purposes. 
The presence of dysmorphic features particularly distal leg wasting and pes cavus, was a good 
clinical indicator of affected members, although by no means pathognomonic. These features 
were also often mild and needed a trained eye to observe them. I did however try and obtain 
the highest level of objectivity with my interpretations by only accepting "distal leg wasting" if 
accompanied by unequivocal EDB atrophy, and "pes cavus" if there was arching of the entire 
plantar surface of the foot off a flat surface. A small number of patients however had normal 
arches and some even had flat feet. 
I did not find any evidence for a separate Roussy-Levy phenotype as tremor was found in 
65% of HSMN I cases and was not necessarily present in all the affected members of a 
particular pedigree. 
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Mental retardation was found to co-segregate with the HSMN II phenotype in 2 Xhosa sisters 
with probable autosomal recessive inheritance (fig. XI). Mental retardation was encountered 
with equal frequency (5%) in affected HSMN I individuals and the examined unaffected family 
members. 
Total absence of deep tendon reflexes was found more frequently in HSMN II whereas 
Harding (21) found this occurrence more commonly in type I. Scoliosis was found in 2 
HSMN I individuals and was not only associated with the ARIS pattern as one case came from 
an AD family. 
Motor examination invariably revealed greater evidence of motor involvement than the patient 
complained about. The distribution of distal weakness in HSMN I and II was predominantly 
in the anterior tibial and peroneal compartments. The leg weakness usually did not progress 
more proximally than the distal thighs. Weakness in fingers usually resulted in clawing. 
Upper limb involvement proximal to the elbows was not found and have only rarely been 
reported (37). 
Diaphragmatic weakness resulting in positional dyspnoea was found in 1 case of HSMN I. 
This is an uncommon occurrence in HSMN. Six cases were described from Queens Square 
Hospital, London, of which 4 were HSMN I and the remaining HSMN II (38). These patients 
like our case, had advanced disease with severe neurologic disability. It is however important 
to recognise this complication as measures reducing nocturnal hypoventilation such as a 
rocking bed or nocturnal positive pressure ventilation, must be instituted if necessary. 
Spasticity was not found in any of the HSMN I or II cases. A condition similar to HSMN II 
but associated with spastic paraplegia, has been previously described (39) but our cases with 
spasticity satisfied the electrophysi°ological criteria of HMN (see HMN-MND) and were 
therefore classified accordingly. 
Total functional disability scores and upper limb involvement were both greater in HSMN type 
II. These findings contrasts with conclusions reached by other groups who found HSMN II to 
be milder and exhibit less arm involvement (26, 34). One possible explanation for this finding 
could be our high proportion of presumed autosomal recessive inheritance together with the 
fact that this pattern of inheritance, at least in HSMN I, is known to be associated with a more 
disabling phenotype than autosomal dominant inheritance. 
Longitudinal electrophysiological data was available in 6 subjects with no apparent change in 
the conduction velocities of the nerves tested over 2 to 17 years in individual cases. Although 
the small number of patients precludes statistical analysis, the data supports the previous 
findings of Gutmann et al. in type I patients ( 40). Dyck found a small increase of a few meters 
per second (2-4 mis) in certain nerves but unfortunately the sample numbers were also small 
and there were no controls to assess comparative test variation in normal individuals (21) . 
Most patients had adapted to their disability extremely well including those with upper limb 
involvement, and some were gainfully employed. A few patients participated in sport or 
dancing activities up until their 2nd to 3rd decades and disability with respect to ambulation 
was generally not severe. 
Curative therapy is unknown at present. Symptomatic therapy for weakness and ankle 
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instability is available as orthotic devices. Most patients had to resort to ankle-foot support in 
their 40's, but only a few required crutches later in life. Only 1 HSMN II patient was not 
ambulatory and 1 needed a wheelchair intermittently. When weakness in the anterior tibial and 
peroneal muscle compartments is significantly greater than the plantar flexors, tendon transfers 
may be considered. Prior to surgery the patient and family should be counselled regarding the 
progressive, albeit slow, nature of the disease as well as the palliative nature of the procedure. 
In certain circumstances when foot drop is severe, stabilization of the ankles by arthrodesis 
may be indicated. 
Despite the fact that this group of diseases only produced relatively "moderate" disability with 
a normal life-span, I encountered a number of individuals that did not want their children to 
know that they had an inherited disease. Most affected cases indicated that they would make 
use of antenatal diagnostic tests for genetic analysis if this were available, and furthermore, 
would be prepared to act on the result. HSMN I is the commonest inherited neuropathy and I 
feel that we should explore genetic analysis for diagnostic purposes so that counselling may be 
offered to affected individuals. Currently , prior to the availability of definitive DNA analysis, 
we have to rely on accurate clinical classification for families requiring genetic counselling, as 
for example, HSMN II in our population is associated with greater functional disability. 
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5. HEREDITARY MOTOR NEUROPATHIES: 
5.1 Results: 
There were 12 patients that fulfilled the criteria for Hereditary motor neuropathies (HMN); 
chronic history of weakness in the legs and electrophysiological evidence of motor nerve 
involvement with entirely normal sensory potentials in all limbs. This group had a mean age of 
35.9 years (SD= 10.61). The hereditary motor neuropathies are a heterogeneous group of 
disorders. Three distinct phenotypes were identified; 
Distal HMN (n=7); 
Scapuloperoneal (n=2); 
Familial Amyotrophic Lateral Sclerosis (F ALS) (Motor neurone disease 
variant (n=3). 
Table 5.1 HMN-subgroups: Racial and sexual distribution: 
HMN-subgroup Race (n) Sex (n) 
Distal w 4 F 5 
MIA 2 M 2 
B 1 
Scapuloperoneal MIA M 2 
I 1 
FALS I 2 M 2 
w 1 F 1 
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5.1 Symptoms: 
Symptom onset in the HMN group was generally in the first and second decade (see fig VI) 
although 1 case presented with symptoms as late as in the 5th decade. Symptoms included 
ankle instability and clumsiness (50%), weak legs (42%), subjective difficulty with gait and 
cramps (25%), and patella disclocation (17%). Weak hands was a subjective symptom in 50% 
of patients, of which 2 experienced the onset from the 3rd decade, 1 in the 4th decade and 3 in 
the 5th decade respectively. One patient only complained of fatiguability (see below). 
Sensory symptoms were present in only 2 individuals; 1 patient with distal-HMN complained 
of numbness in the toes (less than 10 yrs since symptom onset); and 1 patient in the 
Scapuloperoneal (S-P) HMN group complained of paresthesiae in the legs immediately after 
crossing his legs (2 decades since symptom onset). 
Table 5. 2 : Symptoms in HMN 
Symptoms % (n=l2) 
Ankle instability/Clumsiness 50 (6) 
Weak legs 42 (5) 
Gait difficulty 25 (3) 
Cramps 25 (3) 
Weak hands 25 (3) 
Patella disclocation 17 (2) 
Numbness 17 (2) 
F atiguability 8 (1) 
Paresthesiae 8 (1) 
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5.2 Signs: 
Examination revealed wasting of the distal legs and pes cavus (58%), scoliosis (25%) and 
clawing of the toes in 33% ofHMN cases. Wasted intrinsic hand muscles were noted in 17% 
of the HMN group and 1 case had a predominance of upper limb motor involvement 
compared to the lower limbs. 
Clinical evaluation of the motor system in the HMN group showed a mean NDS-W score of 
26.55 (SD= 21.05) which did not differ from HSMN I (p= 0.44). Compared to HSMN II, 
HMN however exhibits less motor weakness (p= 0.05). 
The pattern of weakness was similar to the HSMN group with ankle dorsiflexors being at least 
25% weaker than the plantarflexors in 75% of cases. In half of these subjects with weaker 
ankle dorsiflexors, the difference in power between dorsiflexors and plantarflexors amounted 
to more than 50%. Three individuals whom had no detectable power in the dorsiflexors had 
at least 50% (MRC grade 3) plantar flexion power. None of the HMN cases showed a reverse 
pattern of weakness. A curious distribution of hand muscle weakness was seen in 1 S-P case. 
The thumbs were both flaccid with no detectable power in the thenar extensors. The rest of 
the hand musculature had at least 50% power including the remaining thenar eminence 
muscles. 
Table 5. 3 Signs in HMN 
Signs % (n=12) 
Wasting distal legs 58 (7) 
Pes cavus 58 (7) 
Wasting forearms 42 (5) 
Hammertoes 33 (4) 
Scoliosis 25 (3) 
Wasting proximal 25 (3) 
legs 
Wasted hands 17 (2) 
Short stature 17 (2) 
Pes planus 17 (2) 
Hand clawing 8 (1) 
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Clinical sensory examination in the HMN group showed a mean NDS-S of 3.6 (SD= 4.40) 
which did not differ significantly from the HSMN I mean NDS-S (p= 0.11) but the HSMN II 
cases were found to have significantly greater sensory dysfunction (p= 0.001; Table 4.8). Five 
individuals had entirely normal sensory examinations. One of the distal-HMN subjects whom 
had neither sensory symptoms nor signs on clinical examination however had a large chronic 
ulcer on the lateral aspect of his 1 foot of several years duration. 
Objective gait assessment in HMN showed that 4 patients walked normally; 1 patient had a 
mild footdrop; 2 needed local support and 1 needed crutches (F ALS). 
Thickened nerves, tremor or mental retardation were not found in any of the HMN patients. 
Normal deep tendon reflexes were found in 4 of the distal-HMN group and none of the 
patients with HMN had complete absence of deep tendon reflexes. 
Total disability appeared to be more severe in the 2 S-P HMN cases (mean NDS-T= 55; SD= 
9.99) compared to Distal-HMN (mean NDS-T= 25 .14; SD= 19.56) and FALS cases (mean 
NDS-T= 29.0). A comparison of total disability between HMN and HSMN was not feasible 
as HMN would be expected to have less sensory disability which is incorporated in the total 
disability score. 
5.3 Electrophysiology: 
Med CV was determined in 9 patients with a mean Med CV of 57.6 mis (SD= 4.38). 
Common peroneal conduction speed could only be determined in 8 patients (mean CPer 48 .8 
mis; SD= 8.2) as 4 cases had either denervated EDB muscles or the CMAP was so small that 
a proximal response could not be obtained . 
Electromyography (EMG) showed typical active chronic neurogenic changes in the examined 
muscles of 67% of cases with fibrillation potentials and positive sharp waves. CRD'S were 
more frequently observed than in HSMN. In the majority of cases the motor unit potentials 
consisted of large polyphasic units with a reduced recruitment pattern. In four of the cases, 
including both S-P HMN cases, certain localized regions showed an excess of small motor 
units. Inadequate examination of the muscle may therefore give a false impression of a 
"myopathic" appearance. However, if at least 4 quadrants of a muscle is sampled, the overall 
impression will be that of a neurogenic picture with the presence of large (greater than 2m V) 
polyphasic motor units. These features were confirmed histologically in 1 of the cases. The 
electromyographic examination of more than 1 trajectory in a muscle is therefore imperative. 
Table 5.4 Longitudinal data on conduction velocity (mis-) and CMAP (m V) in HMN: 
Case 
MA: 
1983 
1992 
Case 
MC: 
1984* 
1992 
CPer CV (CMAP) Med CV (CMAP) Ulnar CV (CMAP) 
NR 
NR 
51 
42.7 
(0.2) 
(0.3) 
65 
60.3 
60.0 
62.7 
(12) 
(5.3) 
(4 .0) 
(6 .5) 
60.0 
53 .9 
nd 
(15) 
(4 .5) 
* Performed by MS Schwartz, Dept Neurol. , Atkinson Morley's Hospital, UK. 
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Longitudinal data on nerve conduction velocity was available in 2 cases. (Table 5.4) Both 
individuals showed a mild reduction in nerve speeds although the actual conduction velocity 
was still in the normal range at the follow-up evaluation. As expected with a progressive 
axonopathy, the CMAP amplitude may decrease over several years. 
5.4. Distal -HMN: 
This was the commonest phenotype in the HMN group and was characterised by distal 
weakness and wasting in the legs. Associated distal upper limb involvement was found in 30% 
of cases. One individual with a symptom duration of less than 5 years exhibited predominant 
weakness and wasting in the distal arms. 
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Distal weakness was evident in the lower limbs in all but 1 case. This patient was a 30 year 
old gentleman that had been complaining of increasing exercise intolerance since his second 
decade. The patient claimed that his exercise tolerance improved dramatically with alcohol 
ingestion, but this could not be consistently documented in the laboratory using controlled 
methods such as administering non-alcoholic beer via a nasogastric feeding tube (Dept. Sports 
Medicine, UCT) He had been serially examined by numerous neurologists who documented 
progressive ascending areflexia over 2 decades. No objective evidence of weakness could be 
found on clinical testing, but an EMG and a muscle biopsy showed chronic neurogenic 
changes. His asymptomatic mother was also areflexic, with no other clinical evidence of 
motor or sensory dysfunction. His older brother with similar albeit milder symptoms, was also 
found to be areflexic in the legs. 
The majority of the patients presented with symptoms in the first two decades and 1 case 
experienced his first symptoms in the fifth decade. (Fig. VI) 
Fifty-seven percent of the cases had normal deep tendon reflexes in the upper and lower limbs. 
Two cases in the distal-HMN group had family histories suggestive of definite AD inheritance. 
The family histories of two other subjects suggested ARIS patterns but this could not be 
confirmed. Three of the index cases however had parents with only a history of excessive 
muscle cramps. The latter were found to be normal on neurological examination and 
electromyography was refused. Their cramps all responded dramatically to Quinine Sulphate 
therapy. 
5.5 Scapuloperoneal HMN (S-P HMN) 
These two cases had weakness and wasting of the distal arms and legs associated with 
high-riding scapulae and shoulder girdle weakness. The symptoms started in the patients' 2nd 
and 3rd decade respectively (fig. VI) . They exhibited varying degrees of areflexia in the legs 
and both experienced difficulty with walking. One patient (34 yrs) had bilateral foot drop 
requiring ankle-foot orthoses, and the other (52 yrs) required the additional assistance of a 
walking aid for ambulation. 
The families of the two S-P HMN cases could not be examined but AD inheritance (3 
generations) and AR inheritance (2 affected siblings with unaffected parents and offspring) 
patterns were highly suggestive on history taking in the 2 respective families . 
5.6 Familial Amyotrophic Lateral sclerosis (FALS): 
The first case I felt was consistent with a familial form of MND was a 44 year old white male 
(MP) with a 20 year history of slowly progressive peroneal muscular atrophy and weakness. 
He has been followed up by this neurology unit for the last 14 years, and I have personally 
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been unable to document any objective change over the last 2 years. Examination reveals 
marked peroneal muscle atrophy and weakness associated with proximal hip girdle weakness 
(predominantly L4,5). He also had unequivocal spasticity in the legs with absent ankle jerks 
but very brisk knee jerks with clonus. The sphincters, upper limb and bulbar muscles were 
normal. Sensory examination revealed mild, but unequivocal pain and temperature 
disturbance in the distal feet with vasomotor changes in the lower aspects of the legs. 
Presently he has a waddling gait with bilateral foot drop, and is only able to walk with the aid 
of crutches and ankle foot orthoses. There is no family history of a similar illness and I have 
examined one of his two siblings, who is clinically and neurophysiologically normal. 
I also encountered 2 siblings from a family of Indian origin where a brother (3 7 yrs) and sister 
(34 yrs) both had deafness, short stature, pes planus, scoliosis and peroneal atrophy with 
unequivocally exaggerated lower limb deep tendon reflexes. There was no history of 
consanguinity in family. 
The reasons for classifying these patients as familial MND are; 
a) Chronic history of progressive wasting, weakness and spasticity with 
electrophysiological evidence of motor involvement only, 
b) Clinical evidence of distal lower limb sensory (predominantly small fibre) 
involvement in 2 cases which excludes idiopathic or sporadic MND, 
c) Normal SNAP's electrophysiologically which excludes HSMN. 
All 3 cases had the typical pattern of weakness consistent with the "peroneal muscular 
atrophy" phenotype where ankle dorsiflexors and evertors are disproportionately affected. 
Case MP also had selective proximal weakness and fasciculations in the myotomes that were 
affected distally suggesting discrete bilaterally symmetrical spinal cord motor system 
degeneration. The 2 siblings of Indian origin however exhibited only peroneal and anterior 
tibial weakness but the normal sensory responses on electrophysiological testing excludes 
them from the HSMN type V category. 
Only one of these 3 patients had mild involvement of the upper limbs with finger flexion 
weakness (4th decade since symptoms). 
5.7 HMN Discussion: 
HMN may be clinically difficult to distinguish from HSMN I and II as they are all 
characterized by predominant motor weakness, but electrophysiologically HMN have normal 
sensory conductions (10, 41 ). Motor nerve conductions are usually in the normal range but 
electromyography shows a chronic neurogenic picture with little or no evidence of active 
denervation (10) . 
Consensus has not been reached in the literature regarding the clinical sensory examination 
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findings in HMN. Authors reporting on distal-HMN ("distal SMA") have only included cases 
with normal sensation on clinical as well as electrophysiological testing ( 41 ). The phenotype 
of scapuloperoneal HMN is so characteristic that sensory examination is seldom mentioned 
and in a series of 52 cases of "familial motor neurone disease", 3 cases had clinical evidence of 
distal small fibre sensory loss similar to our patient (MPI), and a further 5 cases complained of 
paresthesiae ( 42). 
I have however included patients with mild subjective and/or objective clinical sensory 
disturbance provided the sensory electrophysiological evaluation was normal, for the following 
reasons: 
a) a significant number of my cases who would have satisfied any other HMN 
protocol, had either symptoms of sensory disturbance which is well recognised in HMN, or 
minimal, occasionally equivocal reduction of sensation on examination, 
b) certain forms of familial motor neuropathy such as the X-linked bulbospinal 
form ("bulbospinal muscular atrophy"), is now known to pathologically involve primary 
sensory neurones (43) . 
The clinical sensory deficit in HSMN I may be very mild and I could not demonstrate a 
significant difference on clinical sensory testing between HSMN I and HMN (Table 4.8; p= 
0.44). The differentiation between these 2 phenotypes could therefore only be made 
electrophysiologically in most instances. HSMN II and HMN both exhibit the typical 
electrophysiological features of a motor axonopathy but differ with respect to the latter's 
normal sensory electrophysiology. 
HMN is also phenotypically heterogeneous even within the same family. The prognosis in 
HMN as in HSMN I is good with the disease showing only slow progression over many 
decades. Individuals with HMN and HSMN often claim that their disease had not 
'progressed' for years to be followed by a subacute deterioration. Certain authors have 
suggested that the disease process may arrest in some individuals although often only 
temporarily although I feel this is most likely due to adaptation by the patient to the slow 
progressive nature of the disease. The patient copes for months to years without noticing any 
change symptomatically. Relatively sudden decompensation is then interpreted as disease 
progression although it is perhaps only the patient's compensation threshold that is exceeded 
and a new status quo has to be reached. 
5.7.1. Distal-HMN: 
Seven cases of distal-HMN was found amongst the 69 cases of familial "peroneal muscular 
atrophies" (10%). Harding and Thomas (44) found 34 "Distal SMA" cases in a series of 262 
(13%) familial neuropathies collected over a decade. Autosomal dominant and recessive 
inheritance patterns have been observed in distal-HMN families (10) . 
Individuals usually presents in the 1st and 2nd decade with progressive symmetrical weakness 
of the distal aspects of either or both upper and lower limbs (41 , 44) We had 1 patient where 
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the wasting and weakness was most prominent in the arms although Jess than 10 years had 
lapsed since disease onset. It has been suggested that families with this presentation may 
represent a distinct subgroup of distal-HMN ( 45). 
Areflexia was much less prominent in distal-HMN than in HSMN I and II. 
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5.7.2. S-P HMN: 
S-P HMN have a pathologically heterogeneous origin which includes myopathy (46, 47); 
neuropathy ( 48); and motor neuronopathy (10, 49 ). Brossard (1886) first described cases 
with a scapuloperoneal distribution of weakness and Hanel (1890) added this description to 
the inherited neuropathies (50, 51). 
The neuropathic varieties of S-P HMN represents an axonal neuropathy with conduction 
velocities in the normal range. There has been one report however of HSMN type I 
presenting with a scapuloperoneal distribution of weakness (37) . Autosomal recessive 
inheritance is common and have an earlier onset and greater functional disability than the less 
frequently encountered autosomal dominant type S-P HMN (10) . 
The weakness usually starts in the shoulder girdle and progresses slowly to the anterior tibial 
muscles and later may involve the pelvic girdle musculature (52). The anterior tibial 
compartment weakness may be so slow and insidious that the patient may have adapted to 
their ' clumsiness and ankle instability' and do not complain of these symptoms spontaneously. 
The patients then presents, as one of ours did, with chronic proximal arm weakness, high 
riding scapulae and more recent onset of proximal lower limb weakness. Another diagnostic 
pitfall may be the occurrence of chronic fasciculations in limb muscles. EMG have also not 
shown concordant results in published series (52) Unwary clinicians, together with a 
confusing EMG picture (see section 5.3), can therefore lead to a misdiagnosis of muscular 
dystrophy or motor neurone disease. 
Mild facial weakness may be seen in S-P HMN I (10) although facial involvement is more 
frequently observed in Scapulo-peroneal myopathy (53) . I have subsequent to the closure of 
my database for analysis, encountered such a patient. She had experienced mild progressive 
symptoms of facial involvement for 4 decades starting initially in the second decade with 
difficulty in whistling and drinking from a straw. Presently in her 6th decade, she has mild 
dribbling of food out of the sides of her mouth when eating. 
Muscle biopsy is often necessary to contribute to the diagnosis but this will also need an 
experienced myologist to distinguish primary from secondary muscle changes in this group 
(52). One of our patients had a confirmatory muscle biopsy (Pathologist: Dr. R Hewlett) . 
Davidenkow reported a number of patients with scapuloperoneal distribution of weakness, pes 
cavus and distal sensory loss, accompanied by reduced motor and sensory conduction 
velocities possibly suggesting a HSMN variant (54, 55). Both our cases (including subsequent 
case) had normal sensory conductions. 
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5.7.3. FALS: 
The term Familial Amyotrophic Lateral sclerosis was coined by the World congress of 
Neurology in September 1990 for the group of inherited motor system disorders with clinical 
evidence of lower and upper motor neuron involvement. Others have however also referred 
to familial motor neuron disease (59) . The incidence of FALS is generally accepted at 
between 5% and 10 % of all cases (56). Although most families show an AD inheritance 
pattern (42, 57, 58) Williams et al (59) found variable penetrance in their Australian AD 
families with some individuals inheriting the gene without developing the disease. 
We are following a woman in her 6th decade who has had signs and symptoms of 
Amyotrophic Lateral Sclerosis (without bulbar involvement) for at least 5 years and still is 
leading an active, independant life. Even though her paternal grandfather died of MND we 
have not included her as an unequivocal familial MND as her father had not displayed the 
phenotype by the age of 76 years when he died of 'cancer', and we have only been able to 
follow her disease clinically for the past 4 years. The short disease duration however does not 
exclude familial MND as the majority of patients in the literature have a disease duration of 
less than 5 years (42, 58, 60). There is thus marked heterogeneity clinically and prognostically 
in this group (42, 58, 60). 
Cases of "peroneal muscular atrophy with spasticity" have been classified as HSMN V, 
although some have been attributed to hypertrophic spinal roots impinging on the spinal cord 
in HSMN I cases (6) . Harding published a series of 22 patients with peroneal muscular 
atrophy and spasticity, of whom only half had absent sensory responses and another third 
exhibited abnormal sensory responses. Five of the cases included in her series had entirely 
normal sensory responses as measured electrophysiologically and she justifies grouping these 
cases with HSMN as 2 cases from the same family each had 'normal', and 'abnormal' SNAP's 
(61). 
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6. Concluding remarks in HSMN and HMN: 
Due to our ignorance regarding the pathophysiology and genetic basis of most of the familial 
neuropathies, various classifications have been proposed and used for decades. All the 
patients that I have described had peroneal muscular atrophy associated with or without other 
features. I have elected to classify the cases using objective electrophysiological 
measurements but I do realize that the ultimate classification will be based on the genetic and 
molecular aspects of these diseases. 
I have attempted, particularly in the HMN subgroups, to describe unusual clincal features that 
I encountered in these patients. I hope this will assist other clinicians when confronted with 
similar cases. The question of peroneal muscular atrophy with spasticity is contentious and I 
think that this will ultimately only be settled by the molecular geneticist. 
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7. HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY (HSAN): 
Five cases from 2 different consanguineous marriages were seen with evidence of 
sensori-motor neuropathy and marked autonomic dysfunction (Fig. XII). There were three 
affected individuals in family A-K aged 39 years (A-K Ill), 44 years (A-K II2), and 49 years 
(A-K II3). Both siblings A-N Ill (33 years) and A-N II2 (39 years) from family A-N, were 
affected. 
Table 7.1 Clinical features 
cases 
sex 
cataracts 
MR 
deafness 
skin lesions 
neuropathy 
pam 
proprioception 
autonomic 
motor 
areflexia 
acral ulcers 
DP - depigmented 
P - pigmented 
A-N Ill A-N 
112 
M F 
+ + 
+ + 
p 
+ + 
+ + 
++ + 
+ + 
A-K A-K A-K 
Ill 113 112 
M M F 
+ + + 
+++ +++ +++ 
+ 
DP DP DP 
+ + + 
+ + + 
++ ++ ++ 
+ + + 
+ + 
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Several clinical characteristics were noted in all 5 cases unless specified (Table 7 .1 ) : 
a) Congenital cataracts - these were surgically removed in infancy. The patients had markedly 
reduced visual acuity with pendular nystagmus. 
b) Mental retardation - the siblings from family A-Kall had profound mental retardation with 
intelligence quotients (Old South African Individual Scale (OSAIS)(6I)) measured as less than 
34. The two affected cases in family A-N both had borderline to moderate mental retardation 
with intelligence quotients (OSAIS) of 84 (A-N Ill) and 36-51 (A-N II2). Both individuals 
could transiently read some Braille in their second decade although they both lost this ability in 
their third decade due to the progressive small and large fibre sensory neuropathy in their 
fingers. 
c) Freckled skin lesions - 4 cases had approximately 0.5- 1.5 cm freckled lesions 
predominantly on the dorsal aspects of the forearms . All 3 cases in family A-K had pigmented 
lesions whereas family A-N II2 had depigmented lesions, in a similar distribution. 
d) All 5 cases had microcephaly (head circumference= 50.3- 53 cm), pes cavus, areflexic legs 
and wasting of the distal hands and feet. Case A-K II3 also had profound hearing loss. 
e) A marked distal sensory neuropathy was found in all 5 subjects. The two members of 
family A-N had severe pain, touch and proprioceptive loss in the legs and fingers . Objective 
evidence of pain loss was found in family A-K, and although objective proprioception could 
not be tested due to oligophrenia, this was most certainly present as evidenced by the wide 
based, high steppage gait exhibited in all three cases. Acral foot ulcers were found in 2 cases. 
f) A marked autonomic neuropathy was present in all 5 individuals. Three of the cases (A-K 
II3 ; A-K II2; A-N II2) had experienced diarrhoea since the second decade and A-K III since 
the age of 5 years. All 5 individuals showed marked postural hypotension with a systolic drop 
in blood pressure ranging from 40-60 mm Hg and a diastolic drop between 55-80 mm Hg. 
The ECG 30 : 15 'R-R' interval ratio was abnormal (1.0) on standing from a supine position 
(normal> 1.04). 
The electrophysiological assessment showed a chronic active distal sensory motor axonopathy 
in the upper and lower limbs with the nerve speeds either in, or just below the normal range 
(mean Med CV= 52.2 mis; SD= 11.9: normal Med CV ~ 48 mis) . Sural, median and ulnar 
digital sensory nerve action potentials were unobtainable. EMG showed chronic neurogenic 
changes in the distal upper and lower limbs with large, polyphasic motor unit potentials. 
Active denervation was present, but Jess prominent in the hands. 
Negative laboratory investigations included; 
Blood count 
Liver functions/electrolytes 
Protein electrophoresis 
Hexosaminidase 
B-Galactosidase 
Lipid profile 
Organic acid screen 
Amino acid screen 
Phytanic acid 
Nerve biopsy 
axonopathy/ 
no amyloid 
MRI brain-normal 
CT brain-normal 
7.1 Discussion : 
cases tested 
5/5 
5/5 
3/5 
3/5 
3/5 
5/5 
5/5 
5/5 
5/5 
1/5 
1/5 
3/5 
47 
These five individuals clearly have the same syndrome characterized by a severe 
"pan-sensory-autonomic" neuropathy and peroneal muscular atrophy associated with 
congenital cataracts, mental retardation and skin lesions. One case also had deafness. This 
particular phenotype has not to my knowledge, been described. 
The sensory neuropathy involved large and small fibres with all 5 sujects exhibiting a sensory 
ataxic gait and the loss of touch sensibility in at least 2 cases. Acral ulcers which are common 
in neuropathies involving the pain and temperature fibers, were seen in 2 subjects. 
The Hereditary Sensory and Autonomic neuropathy (HSAN) group are characterized by an 
insensitivity to pain with normal power and reflexes and abnormal sweating over the acral 
regions. Even though peroneal muscular atrophy, mental retardation and hearing loss may be 
variably associated with HSAN type I and II, these individuals do not develop cardiovascular 
or gastrointestinal autonomic involvement (63) . HSAN III (Familial Dysautonomia) exhibit 
severe postural hypotension and gastrointestinal motility abnormalities from infancy and these 
cases have normal intelligence without any other of our subjects' dysmorphic features (64) . 
The Familial Amyloid Polyneuropathies (F AP) characteristicly have autonomic involvement, 
but they do not show as severe cardiovascular autonomic instability as our patients (65). 
Furthermore the F AP's do not have the dysmorphic features or teenage onset of our cases. A 
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nerve biopsy in 1 case did not reveal any evidence of amyloid deposits (Dr. R Bowen, 
Neuropathology UCT.). 
All the known metabolic causes of neuropathies including adult Refsum's disease have been 
excluded. 
Two Dutch sisters were described in 1991 with mental retardation, cataracts, ataxia, deafness 
and sensory- motor polyneuropathy (66). Two other families with sensory-motor neuropathy 
including ataxia from proprioceptive loss, as well as associated mental retardation and 
deafness have also been reported (67, 68). Autonomic involvement, which is so marked in our 
patients, was however not mentioned in these reports. The Dutch sisters were both older than 
50 years of age whereas our cases presented with the earliest signs of autonomic involvement 
early in their second decades. Furthermore the absence of skin lesions in any of the cases, as 
well as cataracts in the latter two reports distinguishes our two families from the literature. 
The authors of the abovementioned cases could also not demonstrate any known metabollic 
defects. 
We thus describe a new autosomal recessive phenotype of severe sensory and autonomic 
neuropathy with peroneal muscular atrophy, in 2 South African families. These cases resemble 
the HSAN group although the particular constellation of phenotypic traits peculiar to our 
patients, have not been previously described . 
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